Abbott Laboratories Net Profit Margin 2006-2019 | ABT

Current and historical net profit margin for Abbott Laboratories (ABT) from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue. Abbott Laboratories net profit margin for the three months ending September 30, 2019 was .
Abbott Laboratories Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-09-30 $31.36B $3.29B 10.50%
2019-06-30 $30.94B $2.90B 9.36%
2019-03-31 $30.72B $2.62B 8.53%
2018-12-31 $30.58B $2.37B 7.74%
2018-09-30 $30.40B $0.89B 2.91%
2018-06-30 $29.58B $0.93B 3.13%
2018-03-31 $28.45B $0.48B 1.67%
2017-12-31 $27.39B $0.48B 1.74%
2017-09-30 $25.13B $2.10B 8.37%
2017-06-30 $23.61B $1.17B 4.96%
2017-03-31 $22.30B $1.50B 6.74%
2016-12-31 $20.85B $1.40B 6.71%
2016-09-30 $20.71B $1.37B 6.61%
2016-06-30 $20.56B $2.28B 11.08%
2016-03-31 $20.39B $2.45B 12.00%
2015-12-31 $20.41B $4.42B 21.68%
2015-09-30 $20.57B $4.56B 22.17%
2015-06-30 $20.50B $4.52B 22.04%
2015-03-31 $20.39B $4.20B 20.60%
2014-12-31 $20.25B $2.28B 11.28%
2014-09-30 $18.90B $1.97B 10.42%
2014-06-30 $18.65B $2.40B 12.86%
2014-03-31 $19.03B $2.41B 12.65%
2013-12-31 $19.66B $2.58B 13.10%
2013-09-30 $18.84B $3.04B 16.13%
2013-06-30 $19.28B $4.02B 20.83%
2013-03-31 $19.14B $5.27B 27.50%
2012-12-31 $19.05B $5.96B 31.30%
2012-09-30 $26.24B $6.53B 24.88%
2012-06-30 $30.79B $4.89B 15.88%
2012-03-31 $35.09B $5.11B 14.55%
2011-12-31 $38.85B $4.73B 12.17%
2011-09-30 $38.44B $4.55B 11.84%
2011-06-30 $37.30B $5.14B 13.78%
2011-03-31 $36.51B $4.49B 12.29%
2010-12-31 $35.17B $4.63B 13.16%
2010-09-30 $33.99B $4.73B 13.90%
2010-06-30 $33.08B $5.31B 16.07%
2010-03-31 $31.74B $5.31B 16.73%
2009-12-31 $30.76B $5.75B 18.68%
2009-09-30 $29.92B $5.74B 19.19%
2009-06-30 $29.66B $5.35B 18.03%
2009-03-31 $29.48B $5.38B 18.26%
2008-12-31 $29.53B $4.88B 16.53%
2008-09-30 $28.80B $4.55B 15.79%
2008-06-30 $27.68B $4.18B 15.10%
2008-03-31 $26.74B $3.85B 14.39%
2007-12-31 $25.92B $3.61B 13.92%
2007-09-30 $25.52B $1.93B 7.56%
2007-06-30 $24.71B $1.93B 7.80%
2007-03-31 $23.84B $1.55B 6.50%
2006-12-31 $22.48B $1.72B 7.64%
2006-09-30 $21.70B $3.17B 14.60%
2006-06-30 $21.51B $3.13B 14.57%
2006-03-31 $21.54B $3.40B 15.78%
2005-12-31 $22.34B $3.37B 15.10%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $158.560B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $157.266B 21.73
Stryker (SYK) United States $82.983B 26.82
Boston Scientific (BSX) United States $58.973B 26.61
Baxter (BAX) United States $47.553B 28.84
EssilorLuxottica Societe Anonyme (ESLOY) France $33.044B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.992B 20.38
Lonza Group Ag (LZAGY) Switzerland $31.551B 0.00
Coloplast (CLPBY) Denmark $29.743B 45.90
Terumo (TRUMY) Japan $27.160B 0.00
ResMed (RMD) United States $25.539B 44.37
Smith & Nephew SNATS (SNN) United Kingdom $20.941B 0.00
Sunny Optical Technology (SNPTF) China $18.537B 0.00
Insulet (PODD) United States $13.126B 624.47
Bio-Rad Laboratories (BIO) United States $12.082B 56.45
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Perrigo (PRGO) Ireland $7.855B 14.65
Canopy Growth (CGC) Canada $7.731B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 0.00
Hill-Rom Holdings (HRC) United States $7.334B 21.09
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.077B 37.41
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.648B 0.00
ICU Medical (ICUI) United States $4.424B 28.84
NuVasive (NUVA) United States $4.127B 32.50
GW Pharmaceuticals (GWPH) United Kingdom $3.926B 0.00
Neogen (NEOG) United States $3.835B 63.83
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.773B 0.00
Quidel (QDEL) United States $3.367B 29.56
Agios Pharmaceuticals (AGIO) United States $3.033B 0.00
National Vision Holdings (EYE) United States $2.670B 60.27
Aurora Cannabis (ACB) Canada $1.847B 0.00
AtriCure (ATRC) United States $1.734B 0.00
TG Therapeutics (TGTX) United States $1.571B 0.00
Cardiovascular Systems (CSII) United States $1.560B 0.00
InMode (INMD) Israel $1.406B 0.00
NanoString Technologies (NSTG) United States $1.204B 0.00
Aphria (APHA) $1.151B 0.00
Phibro Animal Health (PAHC) United States $1.095B 21.65
VAREX IMAGING (VREX) United States $0.997B 20.71
PetIQ (PETQ) United States $0.956B 23.32
Quanterix (QTRX) United States $0.790B 0.00
Cerus (CERS) United States $0.779B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.721B 27.60
Lantheus Holdings (LNTH) United States $0.653B 16.31
Omeros (OMER) United States $0.653B 0.00
LeMaitre Vascular (LMAT) United States $0.602B 34.22
Surmodics (SRDX) United States $0.535B 61.52
MacroGenics (MGNX) United States $0.497B 0.00
Organigram Holdings (OGI) Canada $0.444B 0.00
HEXO (HEXO) $0.432B 0.00
OraSure Technologies (OSUR) United States $0.422B 25.33
Owens & Minor (OMI) United States $0.420B 15.56
Utah Medical Products (UTMD) United States $0.348B 24.71
Meridian Bioscience (VIVO) United States $0.338B 13.62
Zynex (ZYXI) United States $0.333B 37.63
BioLife Solutions (BLFS) United States $0.313B 127.42
Female Health (VERU) United States $0.275B 0.00
Bovie Medical (APYX) United States $0.268B 0.00
Repro-Med Systems (KRMD) United States $0.238B 0.00
Vapotherm (VAPO) United States $0.219B 0.00
Viemed Healthcare (VMD) United States $0.213B 22.48
United Health Products (UEEC) United States $0.188B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Cytosorbents (CTSO) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.136B 0.00
Fonar (FONR) United States $0.131B 9.52
Chimerix (CMRX) United States $0.103B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
MRI Interventions (CLPT) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
United-Guardian (UG) United States $0.079B 20.02
MTech Acquisition (KERN) United States $0.078B 0.00
Nephros (NEPH) United States $0.071B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) Canada $0.044B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Valeritas Holdings (VLRX) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00